&Partners’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ECAT
SCM
PCM
AAM
&Partners's ECAT Position: Q2 2026 in Review
&Partners increased its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 3.9% in Q2 2026, buying an estimated $15.1K and bringing the position to 26,465 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #1947.
&Partners first reported a position in ECAT in Q2 2024 and has held it in 4 quarters since. 79 funds tracked by Wall St. Rank hold ECAT as of Q2 2026.
- &Partners held 26,465 shares of BlackRock ESG Capital Allocation Term Trust worth $416K as of Q2 2026.
- &Partners bought 1,003 BlackRock ESG Capital Allocation Term Trust shares in Q2 2026, an estimated $15.1K.
- BlackRock ESG Capital Allocation Term Trust made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1947 holding.
- &Partners first reported a position in BlackRock ESG Capital Allocation Term Trust in Q2 2024 and has held it in 4 quarters since.
- 79 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q2 2026.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.